Extravasatie van cytostatica. Hoe de schade kan worden beperkt

J. Oostendorp; A. D.R. Huitema; J. H.M. Schellens; J. H. Beijhen

Extravasatie van cytostatica. Hoe de schade kan worden beperkt

J. Oostendorp, A. D.R. Huitema, J. H.M. Schellens, J. H. Beijhen

Onderzoeksoutput: Bijdrage aan tijdschrift › Artikel › peer review

Samenvatting

Extravasation of cytotoxic drugs may cause severe tissue damage. Extravasation of cytotoxic agents has been estimated to have a frequency ranging from 0.1 to 6.5% of all cytotoxic infusions. In this review several cytostatic agents, known to cause severe local toxicity, are described and possible therapeutic management is recommended. Recently registered cytotoxic agents and newly available forms of therapeutic management will be emphasized.

Vertaalde titel van de bijdrage	How the damage can be limited. Extravasation of cytotoxic drugs
Originele taal-2	Nederlands
Pagina's (van-tot)	1013-1018
Aantal pagina's	6
Tijdschrift	Pharmaceutisch Weekblad
Volume	137
Nummer van het tijdschrift	29
Status	Gepubliceerd - 19 jul. 2002
Extern gepubliceerd	Ja

Trefwoorden

Antineoplastic agents
Drug toxicity
Extravasation
Risk management
Therapeutics

Citeer dit

@article{9f1751b8a0f34d87ad1ad922ed210f56,

title = "Extravasatie van cytostatica. Hoe de schade kan worden beperkt",

abstract = "Extravasation of cytotoxic drugs may cause severe tissue damage. Extravasation of cytotoxic agents has been estimated to have a frequency ranging from 0.1 to 6.5% of all cytotoxic infusions. In this review several cytostatic agents, known to cause severe local toxicity, are described and possible therapeutic management is recommended. Recently registered cytotoxic agents and newly available forms of therapeutic management will be emphasized.",

keywords = "Antineoplastic agents, Drug toxicity, Extravasation, Risk management, Therapeutics",

author = "J. Oostendorp and Huitema, {A. D.R.} and Schellens, {J. H.M.} and Beijhen, {J. H.}",

year = "2002",

month = jul,

day = "19",

language = "Nederlands",

volume = "137",

pages = "1013--1018",

journal = "Pharmaceutisch Weekblad",

issn = "0031-6911",

publisher = "Kon. Ned. Mij. ter Bevordering der Pharmacie (KNMP)",

number = "29",

}

TY - JOUR

T1 - Extravasatie van cytostatica. Hoe de schade kan worden beperkt

AU - Oostendorp, J.

AU - Huitema, A. D.R.

AU - Schellens, J. H.M.

AU - Beijhen, J. H.

PY - 2002/7/19

Y1 - 2002/7/19

N2 - Extravasation of cytotoxic drugs may cause severe tissue damage. Extravasation of cytotoxic agents has been estimated to have a frequency ranging from 0.1 to 6.5% of all cytotoxic infusions. In this review several cytostatic agents, known to cause severe local toxicity, are described and possible therapeutic management is recommended. Recently registered cytotoxic agents and newly available forms of therapeutic management will be emphasized.

AB - Extravasation of cytotoxic drugs may cause severe tissue damage. Extravasation of cytotoxic agents has been estimated to have a frequency ranging from 0.1 to 6.5% of all cytotoxic infusions. In this review several cytostatic agents, known to cause severe local toxicity, are described and possible therapeutic management is recommended. Recently registered cytotoxic agents and newly available forms of therapeutic management will be emphasized.

KW - Antineoplastic agents

KW - Drug toxicity

KW - Extravasation

KW - Risk management

KW - Therapeutics

UR - http://www.scopus.com/inward/record.url?scp=0037135139&partnerID=8YFLogxK

M3 - Artikel

AN - SCOPUS:0037135139

SN - 0031-6911

VL - 137

SP - 1013

EP - 1018

JO - Pharmaceutisch Weekblad

JF - Pharmaceutisch Weekblad

IS - 29

ER -

Extravasatie van cytostatica. Hoe de schade kan worden beperkt

Samenvatting

Trefwoorden

Vingerafdruk

Citeer dit